الفهرس 
Low Back PainOnly 14 pages are availabe for public view
 |  | from | 138 |  |  |
| | | from | 138 | | |
Abstract
Background: Despite widespread use of steroids to treat sacroiliac joint
(SIJ) pain, their duration of pain reduction is short. Injectable platelet-rich
Fibrin (iPRF) can potentially enhance tissue healing and may have a
longer-lasting effect on pain.
Aim and objectives: The objective is to compare the analgesic effect of a
single injection autologous platelet rich fibrin and the commonly used
steroid in ultrasound guided intraarticular sacroiliac joint injection.
Subjects and methods: This randomized clinical study was conducted at
Department of Anesthesiology of Fayoum University hospitals. The study
was conducted on 94 adult patients with sacroiliac dysfunction. All
patients were randomized into 2 equal groups randomly chosen to receive
either PRF (group P, n=47) or Steroid (group S, n=47).
Results: VAS Score immediately after injection in group P had mean ±
SD = 7.51 ± 0.78 while in group S the VAS Score immediately after
injection had mean ± SD = 5.91 ± 0.54 with highly statistical significant
difference (p= <.001) between the two groups, while at 6-month VAS
score had mean ± SD = 3.51 ± 0.78 in group P versus mean ± SD = 4.68
± 0.63 in group S with highly statistical significant difference (p= <.001)
between the two groups.
Conclusion: The intra-articular PRF injection is an effective treatment
modality in low back pain involving SIJ.
Keywords: Sacroiliac joint; VAS; injection; platelet rich fibrin; platelet
rich plasma; steroids.